Follow Us On Social Media

 

NeuroTopic: Neuromuscular & Immune Disorders

Filter Your Results

 

News

 

ACTRIMS 2016 Forum Coverage: Updates in MS Therapeutics and Research

Ted Pigeon, Editor-in-Chief

March 2016—Last month, experts in multiple sclerosis (MS) research and treatment convened in New Orleans, LA for The Americas Committee for Treatment and Research in Multiple Sclerosis (…

Early Diagnosis, Effective Patient Partnerships, and Other Keys to Optimizing Multiple Sclerosis Therapy

Patricia K. Coyle, MD

March 2016—Standardizing imaging protocols and employing strategies to boost adherence can lead to better treatment outcomes.

Preferred Treatment: The Changing Economics of Multiple Sclerosis Care

Thomas P. Leist, MD, PhD

March 2016—By deciding which drugs are “preferred,” insurance companies are reducing the practice of evidence-based medicine to a series of economic choices.

Study Spotlight: Patient Activation and the Psychosocial Impact of Multiple Sclerosis

March 2016—Routine assessment for psychological comorbidities is essential in the overall care of patients with multiple sclerosis.

Ocrelizumab and the Next Phase in Multiple Sclerosis Therapy

Thomas Leist, MD, PhD

November/December 2015—Advances in immune therapy may change how scientists and clinicians understand neurodegenerative components of MS.

Promising Directions in Relapse-Impact Prevention in Multiple Sclerosis

Martina Novotna, MD, Moses Rodriguez, MD, and Orhun H. Kantarci, MD

October 2015—Current immunomodulatory treatments for MS are not reliable to prevent long-term disability, but future agents focusing on remyelination and axonal and neuronal repair could reverse this course.

Multiple Sclerosis in Context: Psychological Comorbidities and Adverse Health Behaviors

With Ruth Ann Marrie, MD, PhD

October 2015—Depression and anxiety are both more prevalent in patients with MS than in the general population. Smoking and alcohol use are also common in these patients. However, while th…

Multiple Sclerosis: In-Focus

October 2015— PRISMS-15 Study Identifies Factors Influencing Long-Term Outcomes in RRMS New findings from the PRISMS-15 study suggest that higher cumulative exposure to subcutaneous …

 
 

Contact Info

For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com

Steve Farrell
National Sales Manager
973-768-8681
sfarrell@bmctoday.com

About Practical Neurology

Launched in January 2002, Practical Neurology strives to enhance quality of care and improve the daily operation of neurology practices. Each month, our experts explain the real-world significance of recent advances in neurologic science and offer step-by-step advice on how to overcome the clinical and business challenges neurologists face. Our straightforward, how-to articles give neurologists tools they can put into practice right away.

 
  • BRYN MAWR COMMUNICATIONS III, LLC